NPC Archive Item: NICE highlights NPC patient decision aid in its lipid guidance

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working.
merec_stop_press NPC Logo

NICE Clinical Guideline 67: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease

Patients should be given information about their absolute risk of cardiovascular disease (CVD) and the likely absolute benefits and harms of treatment in ways meaningful to them, according to recent NICE guidance (see previous blog).  Among the key priorities for implementation, NICE says that:

“People should be offered information about their absolute risk of CVD and about the absolute benefits and harms of an intervention over a 10-year period. This information should be in a form that:

– presents individualised risk and benefit scenarios
– presents the absolute risk of events numerically
– uses appropriate diagrams and text.

The NPC patient decision aid on statins can be found on the lipids section of NPC or by clicking this link.

You can find information and ideas about how to use patient decision aids, including tailoring them to individual patients’ circumstances, in the patient decision aid section of the NPC.  You can also find more information on that floor about the differences between absolute and relative risks and benefits.

Please comment on this blog in the NPC discussion rooms, or using our feedback form